在GPCR信号传递中对配体有效性和强度的分子决定因素
Franziska M Heydenreich1,2,3, Maria Marti-Solano2,4, Manbir Sandhu5
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
概括
了解药物如何与G蛋白结合受体 (GPCR) 相互作用是关键. 这项研究揭示了特定的受体残留物如何转化配体信息以控制药物的疗效和效力,从而帮助新药的设计.
科学领域:
- 药理学
- 结构生物学
- 生物化学
背景情况:
- G蛋白结合受体 (GPCR) 是细胞信号传递中关键的药物点.
- 关联体如何决定受体信号属性,如疗效和功效的分子基础尚未完全理解.
- 了解这些机制对于开发向疗法至关重要.
研究的目的:
- 阐明特定的受体残留如何解码连接体信息以调节信号响应.
- 开发一个数据科学框架,以整合药理和结构数据.
- 发现关键的体药理学网络.
主要方法:
- 使用上腺素-β2上腺素受体-G蛋白系统作为模型.
- 开发了一个数据科学框架,将药理和结构数据结合起来.
- 分析了受体构造变化和全沟通通路.
主要成果:
- 特定的受体残留物负责将配体信息转化为信号结果.
- 揭示了调节依赖连接体的受体激活的异质网络.
- 展示了分析体与受体相互作用的框架.
结论:
- 特定的受体残留在确定药物的有效性和强度方面起着至关重要的作用.
- 开发的数据科学框架提供了对联体受体信号的洞察力.
- 这种方法可以指导设计具有量身定制药理特征的新药.
相关概念视频
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
G Protein-coupled Receptors
12.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.1K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K


